Compare FUNC & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FUNC | SWKH |
|---|---|---|
| Founded | 1900 | 1996 |
| Country | United States | United States |
| Employees | N/A | 9 |
| Industry | Major Banks | Diversified Financial Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.8M | 198.4M |
| IPO Year | 2012 | N/A |
| Metric | FUNC | SWKH |
|---|---|---|
| Price | $37.00 | $16.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 5.4K | ★ 104.8K |
| Earning Date | 04-20-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ 19.68 | N/A |
| EPS | ★ 3.77 | N/A |
| Revenue | ★ $18,426,000.00 | N/A |
| Revenue This Year | $13.05 | N/A |
| Revenue Next Year | $6.56 | N/A |
| P/E Ratio | $9.81 | ★ $9.18 |
| Revenue Growth | ★ 4.01 | N/A |
| 52 Week Low | $28.00 | $13.32 |
| 52 Week High | $41.95 | $17.90 |
| Indicator | FUNC | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 32.19 |
| Support Level | $35.93 | $14.69 |
| Resistance Level | $38.11 | $17.08 |
| Average True Range (ATR) | 0.85 | 0.37 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 8.38 | 12.06 |
First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.